NCT07681596
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07681596
Title A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma
Recruitment Not yet recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | AUS

Facility Status City State Zip Country Details
Research Site Duarte California 91010 United States Details
Research Site Denver Colorado 80218 United States Details
Research Site Tampa Florida 33612 United States Details
Research Site Atlanta Georgia 30322 United States Details
Research Site St Louis Missouri 63110 United States Details
Research Site Hackensack New Jersey 07601 United States Details
Research Site Cleveland Ohio 44195 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Houston Texas 77030 United States Details
Research Site Milwaukee Wisconsin 53226 United States Details
Research Site Camperdown 2050 Australia Details
Research Site East Melbourne 3002 Australia Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field